ABEO Abeona Therapeutics Inc.

NASDAQ
$2.42

Abeona Therapeutics Inc. (ABEO) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with ABEO's own trailing one-year pace, with 7% of sale value under a prearranged plan.
Cluster activity 1 buyer in the last 30 days 1 buyer in the last 90 days 5 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
7
21 transactions
Purchases
$34.3K
15,000 shares
Sales
$2.0M
330,006 shares
Net activity
-$1.9M
purchases less sales

How much of that selling was preplanned? 7% planned / 93% discretionary

10b5-1 plan sales $138.3K 1 transaction · 25,646 shares
Discretionary sales $1.8M 20 transactions · 304,360 shares

Largest single sale: $473.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 13, 2026 , by Charles Faith L. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Charles Faith L. Director Buy 15,000 $2.29 $34.3K 191,407
Seshadri Vishwas Chief Executive Officer Sell 19,608 $5.16 $101.1K 1,286,500 −1.5% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 9,191 $5.16 $47.4K 482,888 −1.9% of holding
O'Malley Brendan M. SVP, Chief Legal Officer Sell 6,727 $5.16 $34.7K 421,226 −1.6% of holding
Vasanthavada Madhav Chief Commercial Officer Sell 4,902 $5.16 $25.3K 285,721 −1.7% of holding
Alvino Mark Director Sell 15,000 $5.86 $88.0K 62,065 −19.5% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 1,478 $6.53 $9.7K 492,079 −0.3% of holding
Seshadri Vishwas Chief Executive Officer Sell 67,971 $6.96 $473.3K 1,306,108 −4.9% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 24,880 $6.96 $173.3K 493,557 −4.8% of holding
Vasanthavada Madhav Chief Commercial Officer Sell 12,606 $6.96 $87.8K 290,623 −4.2% of holding
O'Malley Brendan M. SVP, Chief Legal Officer Sell 12,050 $6.96 $83.9K 427,953 −2.7% of holding
Alland Leila Director Sell 11,000 $5.92 $65.1K 162,614 −6.3% of holding
Silverstein Christine Berni Director Sell 18,160 $5.71 $103.7K 119,562 −13.2% of holding
Seshadri Vishwas Chief Executive Officer Sell 31,916 $5.30 $169.3K 1,374,079 −2.3% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 10b5-1 25,646 $5.39 $138.3K 518,437 −4.7% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 13,421 $5.30 $71.2K 544,083 −2.4% of holding
O'Malley Brendan M. SVP, Chief Legal Officer Sell 6,305 $5.30 $33.4K 440,003 −1.4% of holding
Vasanthavada Madhav Chief Commercial Officer Sell 5,450 $5.30 $28.9K 303,451 −1.8% of holding
Seshadri Vishwas Chief Executive Officer Sell 24,428 $5.43 $132.6K 1,405,995 −1.7% of holding
Vazzano Joseph Walter Chief Financial Officer Sell 10,271 $5.43 $55.8K 557,504 −1.8% of holding
O'Malley Brendan M. SVP, Chief Legal Officer Sell 4,826 $5.43 $26.2K 446,308 −1.1% of holding
Vasanthavada Madhav Chief Commercial Officer Sell 4,170 $5.43 $22.6K 308,901 −1.3% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.